Shares of Vedanta and Dr Reddy’s Labs fell up to 4 per cent on BSE as the 30-share Sensex rejig came into effect on Monday.
Under the reconstitution, Vedanta has entered the benchmark index, while Dr Reddy’s Labs has exited the index.
Vedanta, after opening the day on a weak note, further fell by 4.16 per cent to Rs 228.80 — its 52-week low — as the trade progressed on BSE.
The stock was also among the biggest losers in the metals pack on BSE, which turned negative on increasing concerns over a full-fledged trade war between the US and China after Donald Trump on Friday slapped a 25 per cent tariff on $50 billion worth of Chinese goods.
With the exclusion of Dr Reddy’s Labs and due to the significant underperformance of the sector over the last two years, the weight of healthcare in the index will now be at an eight-year low, broking firm Motilal Oswal said last week in its India Strategy report.
With the inclusion of Vedanta in the benchmark, metal sector weight will increase to 2.6 per cent, the report had said.
The reconstitution in BSE indices was announced on 18 May.
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.
